ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence

NCT00981617 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

406

Enrollment

INDUSTRY

Sponsor class

Conditions

Alcohol Dependence

Interventions

DRUG: ALKS33 (RDC-0313) (1 mg)
DRUG: ALKS33 (RDC-0313) (2.5 mg)
DRUG: ALKS33 (RDC-0313) (10 mg)
DRUG: Placebo

Sponsor

Alkermes, Inc.